Ferric Carboxymaltose
A macromolecular intravenous iron complex for treating iron-deficiency anaemia in a single, controlled infusion.
Injectable-grade intravenous iron API
Ferric Carboxymaltose is a macromolecular intravenous iron complex used to treat iron-deficiency anaemia, particularly where oral iron is ineffective, poorly tolerated or too slow. It consists of a polynuclear iron(III)-oxyhydroxide core stabilised by a carboxymaltose carbohydrate shell, which allows a large dose of iron to be given in a single, controlled infusion.
Because the iron is released in a controlled manner from the stable complex, it supports rapid replenishment of iron stores and correction of haemoglobin with a favourable tolerability profile — making it a preferred choice for modern IV iron therapy across multiple clinical settings.
How it works
High single-dose delivery
A stable iron–carbohydrate complex enables high single-dose iron delivery.
Controlled release
Iron is released gradually and taken up by the body’s iron-transport and storage system.
Fewer doses needed
Reduces the need for repeated dosing compared with older IV iron products.
Key applications
Iron-deficiency anaemia
Intravenous treatment of iron-deficiency anaemia.
CKD & IBD
Chronic kidney disease and inflammatory bowel disease.
Injectable formulations
Peri-operative, post-partum anaemia and infusion formulation development.
Product specifications (typical)
| CAS No. | 9007-72-1 |
|---|---|
| Type | Polynuclear iron(III)-oxyhydroxide / carboxymaltose complex (macromolecular) |
| Molecular Formula | C24H44FeO25 |
| Molecular Weight | ≈ 788.4 g/mol |
| Appearance | Dark brown powder / solution |
| Iron content & assay | As per agreed / pharmacopoeial specification |
| Category | Intravenous iron API |
As a macromolecular iron–carbohydrate complex, the molecular formula and weight shown correspond to its characteristic complex unit; the product is ultimately defined by its iron content and pharmacopoeial specification. COA, SDS and technical documentation provided with every batch.
Quality & compliance
- Pharmaceutical-grade, injectable-quality manufacturing
- Complete COA, SDS and technical documentation
- Controlled specifications suitable for parenteral use
Packaging & storage
Supplied in pharma-grade packaging as agreed. Store cool and dry, protected from light; handle per SDS.
Why choose Narmada Organics
Pharmaceutical, injectable-quality material with controlled specifications.
Scalable, dependable supply for formulation partners.
Complete COA, SDS and technical specs with every shipment.
Frequently asked questions
What is Ferric Carboxymaltose used to treat?
It is an intravenous iron used to treat iron-deficiency anaemia, especially when oral iron is ineffective or not tolerated (e.g. CKD, IBD, post-partum, peri-operative).
Is it suitable for injectable / parenteral formulations?
Yes — we supply pharmaceutical, injectable-quality material with controlled specifications for parenteral use.
Does it have a simple molecular formula?
No — it is a macromolecular iron(III)-carbohydrate complex, so it is defined by its iron content and specification rather than a single formula.
Do you provide documentation and bulk supply?
Yes. Full COA, SDS and technical specs with every shipment, with scalable supply and global export.
Need injectable-grade Ferric Carboxymaltose?
Get specifications, COA and pricing for parenteral-grade supply. Our team responds within one business day.